Multiple myeloma is a disease characterized by the proliferation of malignant plasma cells, the over-production of a monoclonal immunoglobulin (paraprotein) and the subsequent depression of the other normal immunoglobulins. Whereas many patients respond to treatment and enter a plateau phase of variable duration, these patients eventually die of their disease. This report describes a patient with Stage III multiple myeloma diagnosed in 1966 and now with documentation of prolonged disease-free survival and perhaps cure, with the patient presently alive and well without evidence of disease.
No takes yet. Share an insight, caveat, or question.
Dutcher et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: